Product Name
Delta-like 1 (DLL3), Monoclonal Antibody
Full Product Name
Delta-like 1 (DLL1, Delta1, DL1, H-Delta-1, UNQ146/PRO172)
Product Synonym Names
Anti -Delta-like 1 (DLL1, Delta1, DL1, H-Delta-1, UNQ146/PRO172)
Product Gene Name
anti-DLL3 antibody
[Similar Products]
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
Chromosome Location
Chromosome: 19; NC_000019.9 (39989557..39999121). Location: 19q13
3D Structure
ModBase 3D Structure for Q9NYJ7
Specificity
Recognizes recombinant human DLL1 in direct ELISAs. Does not crossreact with recombinant human DLL3 or recombinant human DLL4.
Purity/Purification
Affinity Purified
Purified by Protein G affinity chromatography.
Form/Format
Supplied as a lyophilized powder from PBS with 5% trehalose. Reconstitute with 200ul sterile PBS.
Immunogen
Recombinant corresponding to aa22-540 from human Delta-like 1 expressed in NSO cells (Accession #AAG09716).
Preparation and Storage
Lyophilized powder may be stored at -20 degree C. Stable for 12 months at -20 degree C. Reconstitute with sterile PBS. Aliquot to avoid repeated freezing and thawing. Store at -20 degree C. Reconstituted product is stable for 12 months at -20 degree C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
Other Notes
Small volumes of anti-DLL3 antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
anti-DLL3 antibody
Delta-like protein 1 (DLL1) is a 90-100kD type I transmembrane protein that belongs to the Delta/Serrate/Lag-2 (DSL) family of Notch ligands. Mature human DLL1 consists of a 528 amino acid (aa) extracellular domain (ECD) with one DSL domain and eight EGF-like repeats, a 23aa transmembrane segment and a 155aa cytoplasmic domain (1). Within the ECD, human DLL1 shares 91% aa sequence identity with mouse and rat DLL1. It shares 26%, 37% and 54% aa sequence identity with DLL2, 3 and 4, respectively. A 60kD ECD fragment released by ADAM9, 12 or 17 mediated proteolysis, promotes the proliferation of hematopoietic progenitor cells (2, 3). The residual membrane-bound portion of DLL1 can be cleaved by presenilin-dependent gamma-secretase, enabling the cytoplasmic domain to migrate to the nucleus (4). DLL1 localizes to adherens junctions on neuronal processes through its association with the scaffolding protein MAGI1 (5). DLL1 is widely expressed, and it plays an important role in embryonic somite formation, cochlear hair cell differentiation, plus B and T lymphocyte differentiation (6-11). The upregulation of DLL1 in arterial endothelial cells following injury or angiogenic stimulation is central to postnatal arteriogenesis (12). DLL1 is also overexpressed in cervical carcinoma and glioma and contributes to tumor progression (1, 13).
Product Categories/Family for anti-DLL3 antibody
Antibodies; Abs to Notch Proteins
Applications Tested/Suitable for anti-DLL3 antibody
ELISA (EL/EIA), Immunohistochemistry (IHC), Immunocytochemistry (ICC)
Application Notes for anti-DLL3 antibody
Suitable for use in ELISA, Immunocytochemistry and Immunohistochemistry.
Dilution: Immunocytochemistry: 8-25ug/ml detects DLL1 in immersion fixed HepG2 human hepatocellular carcinoma cell line.
Immunohistochemistry: 8-25ug/ml detects DLL1 in immersion fixed paraffin embedded human squamous cell carcinoma tissue sections.
Optimal dilutions should be determined by the researcher.
NCBI/Uniprot data below describe general gene information for DLL3. It may not necessarily be applicable to this product.
NCBI Accession #
NP_058637.1
[Other Products]
NCBI GenBank Nucleotide #
NM_016941.3
[Other Products]
UniProt Primary Accession #
Q9NYJ7
[Other Products]
UniProt Secondary Accession #
Q8NBS4; E9PFG2[Other Products]
UniProt Related Accession #
Q9NYJ7[Other Products]
Molecular Weight
64,618 Da[Similar Products]
NCBI Official Full Name
delta-like protein 3 isoform 1
NCBI Official Synonym Full Names
delta-like 3 (Drosophila)
NCBI Official Symbol
DLL3 [Similar Products]
NCBI Official Synonym Symbols
SCDO1
[Similar Products]
NCBI Protein Information
delta-like protein 3; delta3; drosophila Delta homolog 3
UniProt Protein Name
Delta-like protein 3
UniProt Synonym Protein Names
Drosophila Delta homolog 3
Protein Family
Delta-like protein
UniProt Gene Name
DLL3 [Similar Products]
UniProt Synonym Gene Names
Delta3 [Similar Products]
UniProt Entry Name
DLL3_HUMAN
NCBI Summary for DLL3
This gene encodes a member of the delta protein ligand family. This family functions as Notch ligands that are characterized by a DSL domain, EGF repeats, and a transmembrane domain. Mutations in this gene cause autosomal recessive spondylocostal dysostosis 1. Two transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Jul 2008]
UniProt Comments for DLL3
DLL3: Inhibits primary neurogenesis. May be required to divert neurons along a specific differentiation pathway. Plays a role in the formation of somite boundaries during segmentation of the paraxial mesoderm. Can bind and activate Notch-1 or another Notch receptor.
Protein type: Membrane protein, integral; Cell development/differentiation
Chromosomal Location of Human Ortholog: 19q13
Cellular Component: integral to membrane
Molecular Function: Notch binding
Biological Process: compartment specification; paraxial mesoderm development; Notch signaling pathway; somitogenesis; skeletal development; negative regulation of neurogenesis
Disease: Spondylocostal Dysostosis 1, Autosomal Recessive
Research Articles on DLL3
1. DLL3 was silenced by methylation in human human hepatocellular carcinoma and it negatively regulates the growth of human hepatocellular carcinoma cells.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.